Advertisement
Screener

PHARMACEUTICAL PRODUCT DEVELOPMENT INC Defined Benefit Plan, Expected Return (Loss) on Plan Assets

PHARMACEUTICAL PRODUCT DEVELOPMENT INC Defined Benefit Plan, Expected Return (Loss) on Plan Assets

PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Defined Benefit Plan, Expected Return (Loss) on Plan Assets of $745.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.

Discontinued › Notes › Compensation Related Costs

us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets · last filed 2011-11-02

  • PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, expected return (loss) on plan assets for the quarter ending 2011-09-30 was $745.00K, a 20.36% increase year-over-year.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, expected return (loss) on plan assets for the quarter ending 2011-06-30 was $755.00K, a 26.89% increase year-over-year.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, expected return (loss) on plan assets for the quarter ending 2010-09-30 was $619.00K.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT INC defined benefit plan, expected return (loss) on plan assets for the quarter ending 2010-06-30 was $595.00K.
Period endDefined Benefit Plan, Expected Return (Loss) on Plan Assets 3 monthDefined Benefit Plan, Expected Return (Loss) on Plan Assets 6 monthDefined Benefit Plan, Expected Return (Loss) on Plan Assets 9 month
2011-09-30$745.00K
10-Q · filed 2011-11-02
$1.50M
derived: sum of 2 quarters · filed 2011-11-02
$2.24M
10-Q · filed 2011-11-02
2011-06-30$755.00K
10-Q · filed 2011-08-04
$1.50M
10-Q · filed 2011-08-04
2010-09-30$619.00K
10-Q · filed 2011-11-02
$1.21M
derived: sum of 2 quarters · filed 2011-11-02
$1.84M
10-Q · filed 2011-11-02
2010-06-30$595.00K
10-Q · filed 2011-08-04
$1.22M
10-Q · filed 2011-08-04